Effectiveness of Psychological Interventions for Treating Chronic Prostatitis/chronic Pelvic Pain Syndrome: A Protocol for Systematic Review and Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2020 Sep 29

PMID 32991409

Citations 5

Authors

Yuanjie Xu

Ling Zhang

Yifeng Shen

Hangyu Yao

Shanshan Yong

Yaodong You

Affiliations

Soon will be listed here.

Abstract

Introduction: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is one of the most common diseases in urology, which 50% of men are infected at some point in their lives. Type III CP/CPPS is the most complex and controversial of all types of prostatitis, the highest incidence rate, uncertain efficacy, the long-term treatment that affects the patient's psychopathic symptoms, increases the psychological burden of patients. Psychological intervention for patients with CP/CPPS, which is difficult to treat with drugs and physics, can effectively improve clinical efficacy and improve the psychological condition. The researchers found a high prevalence of psychosocial problems and catastrophic distress in CP/CPPS patients, such as serious mental disorders, especially depression, anxiety and stress, and the high incidence of pain-devastating illness. In this study, we will evaluate psychological interventions as an effective way to relieve chronic prostatitis.

Methods And Analysis: The databases of English databases (PubMed, MEDLINE, EMBASE, Web of Science, Cochrane Library) and Chinese databases (China National Knowledge Infrastructure, China Biology Medicine Database, Wanfang Database, VIP Database) will be retrieved. The search strategy that will be run in the PubMed and tailored to the other database when necessary is presented in this article. RevMan 5.3 and Stata 11.0 will be used for Systematic Review and Meta-analysis. This protocol reported under the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement, and we will report the systematic review by following the PRISMA statement.

Results: The study is a protocol for systematic review and meta-analysis without results, and data analysis will be carried out after the protocol. We will share our findings in the third quarter of 2021.

Conclusion: This systematic review will provide more evidence to assess whether psychological is an effective intervention for patients with chronic prostatitis/chronic pelvic pain syndrome. Besides, the results will be published in a public issue journal and offer the urologists help to make clinical decisions.

Ethics And Dissemination: Formal ethical approval is not required in this protocol. We will collect and analyze data based on published research. Since this research does not involve patients, personal privacy will not be affected. The results of this review will be distributed to peer-reviewed journals or submitted to relevant conferences.

Protocol Registration Number: INPLASY202080021.

Citing Articles

Clinical efficacy of magnetic vibration magnetoelectric therapy in the treatment of chronic prostatitischronic pelvic pain syndrome.

Zhang Z, Chang F, Chen Y World J Clin Cases. 2024; 12(19):3837-3844.

PMID: 38994312 PMC: 11235469. DOI: 10.12998/wjcc.v12.i19.3837.

The effect of calcium oxalate stones and uric acid stones on male sexual function.

Chen J, Pang N, Lu J, Liu G, Lee S, Wang W Int Urol Nephrol. 2024; 57(1):19-25.

PMID: 38958853 DOI: 10.1007/s11255-024-04127-0.

Comparing the effectiveness of extracorporeal shockwave therapy and myofascial release therapy in chronic pelvic pain syndrome: study protocol for a randomized controlled trial.

Huang N, Qin Z, Sun W, Bao K, Zha J, Zhang P Trials. 2023; 24(1):675.

PMID: 37853420 PMC: 10583345. DOI: 10.1186/s13063-023-07633-1.

The ALFF Alterations of Spontaneous Pelvic Pain in the Patients of Chronic Prostatitis/Chronic Pelvic Pain Syndrome Evaluated by fMRI.

Ge S, Hu Q, Xia G, Tan Y, Guo Y, Sun C Brain Sci. 2022; 12(10).

PMID: 36291278 PMC: 9599805. DOI: 10.3390/brainsci12101344.

Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience.

Zhang Z, Su X, Cai C, Wang Z Comput Math Methods Med. 2022; 2022:9227032.

PMID: 35547566 PMC: 9085319. DOI: 10.1155/2022/9227032.

References

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

Keltikangas-Jarvinen L, Jarvinen H, Lehtonen T . Psychic disturbances in patients with chronic prostatis. Ann Clin Res. 1981; 13(1):45-9. View

Rees J, Abrahams M, Doble A, Cooper A . Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015; 116(4):509-25. PMC: 5008168. DOI: 10.1111/bju.13101. View

Pirola G, Verdacchi T, Rosadi S, Annino F, De Angelis M . Chronic prostatitis: current treatment options. Res Rep Urol. 2019; 11:165-174. PMC: 6556531. DOI: 10.2147/RRU.S194679. View

Krieger J, Nyberg Jr L, Nickel J . NIH consensus definition and classification of prostatitis. JAMA. 1999; 282(3):236-7. DOI: 10.1001/jama.282.3.236. View

Habermacher G, Chason J, Schaeffer A . Prostatitis/chronic pelvic pain syndrome. Annu Rev Med. 2006; 57:195-206. DOI: 10.1146/annurev.med.57.011205.135654. View

Motrich R, Breser M, Molina R, Tissera A, Olmedo J, Rivero V . Patients with chronic prostatitis/chronic pelvic pain syndrome show T helper type 1 (Th1) and Th17 self-reactive immune responses specific to prostate and seminal antigens and diminished semen quality. BJU Int. 2020; 126(3):379-387. DOI: 10.1111/bju.15117. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

Mehik A, Hellstrom P, Sarpola A, Lukkarinen O, Jarvelin M . Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int. 2001; 88(1):35-8. DOI: 10.1046/j.1464-410x.2001.02259.x. View

10.

Ginting J, Tripp D, Nickel J . Self-reported spousal support modifies the negative impact of pain on disability in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2011; 78(5):1136-41. PMC: 3210439. DOI: 10.1016/j.urology.2011.03.073. View

11.

Shea B, Reeves B, Wells G, Thuku M, Hamel C, Moran J . AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017; 358:j4008. PMC: 5833365. DOI: 10.1136/bmj.j4008. View

12.

Shoskes D, Nickel J, Kattan M . Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology. 2010; 75(6):1249-53. DOI: 10.1016/j.urology.2010.01.021. View

13.

Shoskes D, Nickel J, Dolinga R, Prots D . Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009; 73(3):538-42. DOI: 10.1016/j.urology.2008.09.074. View

14.

Cohen J, Fagin A, Hariton E, Niska J, Pierce M, Kuriyama A . Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One. 2012; 7(8):e41941. PMC: 3411608. DOI: 10.1371/journal.pone.0041941. View

15.

Ihsan A, Ullah Khan F, Khongorzul P, Ahmad K, Naveed M, Yasmeen S . Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress. Biomed Pharmacother. 2018; 106:714-723. DOI: 10.1016/j.biopha.2018.06.139. View

16.

Kullisaar T, Turk S, Punab M, Mandar R . Oxidative stress--cause or consequence of male genital tract disorders?. Prostate. 2011; 72(9):977-83. DOI: 10.1002/pros.21502. View

17.

Zhao Z, Zhang J, He J, Zeng G . Clinical utility of the UPOINT phenotype system in Chinese males with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a prospective study. PLoS One. 2013; 8(1):e52044. PMC: 3547952. DOI: 10.1371/journal.pone.0052044. View

18.

Krakhotkin D, Chernylovskyi V, Bakurov E, Sperl J . Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study. Ther Adv Urol. 2019; 11:1756287219857271. PMC: 6595637. DOI: 10.1177/1756287219857271. View

19.

Shahed A, Shoskes D . Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl. 2000; 21(5):669-75. View

20.

Nickel J, Mullins C, Tripp D . Development of an evidence-based cognitive behavioral treatment program for men with chronic prostatitis/chronic pelvic pain syndrome. World J Urol. 2008; 26(2):167-72. DOI: 10.1007/s00345-008-0235-6. View